Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Neogen (NEOG) EBT (2016 - 2026)

Neogen has reported EBT over the past 17 years, most recently at -$20.3 million for Q1 2026.

  • For Q1 2026, EBT fell 109.28% year-over-year to -$20.3 million; the TTM value through Feb 2026 reached -$628.1 million, down 23.57%, while the annual FY2025 figure was -$1.1 billion, 7821.08% down from the prior year.
  • EBT for Q1 2026 was -$20.3 million at Neogen, roughly flat from -$20.4 million in the prior quarter.
  • Over five years, EBT peaked at $43.8 million in Q3 2025 and troughed at -$631.2 million in Q2 2025.
  • A 5-year average of -$67.1 million and a median of -$5.8 million in 2024 define the central range for EBT.
  • Biggest five-year swings in EBT: crashed 12618.76% in 2024 and later surged 380.66% in 2025.
  • Year by year, EBT stood at -$34.1 million in 2022, then surged by 89.01% to -$3.7 million in 2023, then crashed by 12618.76% to -$476.6 million in 2024, then surged by 95.73% to -$20.4 million in 2025, then increased by 0.31% to -$20.3 million in 2026.
  • Business Quant data shows EBT for NEOG at -$20.3 million in Q1 2026, -$20.4 million in Q4 2025, and $43.8 million in Q3 2025.